Favourites   Have ideas?  Sign in / Register

Positive:   RNA ↓6   Gene and cell ↓5.58   Health Devices ↓3.55 «See more»   Pharmaceutical  ↑3.19   Country: Canada ↑5.97   Laser ↑6.92

Negative:


Disease: Eye segment

AERI Aerie Pharmaceuticals, Inc. - Common Stock 8.46% 8.46% 0 + Disease: Eye , Medicine, Pharmaceutical


Last highlighted: Alert [Press/News Current Report] / Form 8-K filed with the SEC $AERI AERIE PHARMACEUTICALS INC https://t.co/jhemDQoMVR
+ My List
ALIM Alimera Sciences, Inc. - Common Stock -6.95% up -7.47% 0.52 + Disease: Eye , Biopharma, Medicine

+ My List
ATRI Atrion Corporation - Common Stock 1.22% down 7.4% -6.18 + Disease: Cardiovascular, Disease: Eye , Medicine, Devices

+ My List
CLSD Clearside Biomedical, Inc. - Common Stock -7.14% up -9.09% 1.95 + Disease: Eye , Medicine, Biopharma

+ My List
EYEG Eyegate Pharmaceuticals, Inc. - Common Stock 0.00% 0 + Disease: Eye , Medicine

+ My List
EYES Second Sight Medical Products, Inc. - Common Stock -7.1% -7.1% 0 + Medicine, Health Devices, Disease: Eye


Last highlighted: @OliverKennett Not that I'm aware of, except for stock traders trying to manipulate pricing with reports, bullish ratings, blah, blah https://t.co/7s39zUQctu
+ My List
EYESW Second Sight Medical Products, Inc. - Warrants expiring 3/14/2024 0 + Medicine, Health Devices, Disease: Eye

+ My List
EYPT EyePoint Pharmaceuticals, Inc. - Common Stock 5.17% up -9.76% 14.93 + Pharmaceutical , Disease: Eye , Medicine, Biopharma


Last highlighted: #EYPT SEC report: EyePoint Pharmaceuticals, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by EyePoint Pharmaceuticals, Inc. -- SEC File Number 211142305
+ My List
GHSI Guardion Health Sciences, Inc. - Common Stock 0 + Disease: Eye , Medicine, Food, Devices


Last highlighted: #GHSI SEC report: Guardion Health Sciences, Inc. [Amend] Current report, items 2.01, 8.01, and 9.01
SEC Filing Form 8-K/A filed by Guardion Health Sciences, Inc. -- SEC File Number 211161197
+ My List
GRAY Graybug Vision, Inc. - Common Stock up -10.28% 10.28 + Medicine, Disease: Eye

+ My List
IRIX IRIDEX Corporation - Common Stock 6.92% up -12.2% 19.12 + Disease: Eye , Laser, Medicine, Devices


Last highlighted: #IRIX SEC report: IRIDEX CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by IRIDEX CORP -- SEC File Number
+ My List
KALA Kala Pharmaceuticals, Inc. - Common Stock 0 + Disease: Eye , Disease: Gastrointestinal, Medicine, Biopharma

+ My List
KOD Kodiak Sciences Inc - Common Stock 8.11% 8.11% 0 + Biopharma, Disease: Eye , Medicine

+ My List
MITO Stealth BioTherapeutics Corp. - American Depositary Shares 0 + Medicine, Biopharma, Disease: Eye

+ My List
OCGN Ocugen, Inc. - Common Stock 6.81% down 7.34% -0.53 + Medicine, Disease: Eye


Last highlighted: #OCGN SEC report: Ocugen, Inc. Current report, items 8.01 and 9.01
+ My List
OCUP Ocuphire Pharma, Inc. - Common Stock -4.07% -4.07% 0 + Disease: Eye , Biopharma, Medicine, Pharmaceutical


Last highlighted: $OCUP 📜 Ocuphire Pharma, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits https://t.co/xMAN0ucl8b 15s delayed.
+ My List
OPT Opthea Limited - American Depositary Shares 5.97% down 10.41% -4.44 + Disease: Eye , Country: Canada, Medicine

+ My List
OTLK Outlook Therapeutics, Inc. - Common Stock 1.27% down 12.5% -11.23 + Disease: Eye , Biopharma, Medicine


Last highlighted: #OTLK SEC report: Outlook Therapeutics, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by Outlook Therapeutics, Inc. -- SEC File Number
+ My List
PRQR ProQR Therapeutics N.V. - Ordinary Shares -6% up -7% 1 + Medicine, Biotechnology, Disease: Eye , RNA

+ My List
TARS Tarsus Pharmaceuticals, Inc. - Common Stock 6.82% up -7.35% 14.17 + Medicine, Disease: Eye

+ My List
FDMT 4D Molecular Therapeutics, Inc. - Common Stock -5.58% up -8.25% 2.67 + Medicine, Gene and cell, Disease: Eye

+ My List
VRDN Viridian Therapeutics, Inc. - Common Stock 0.00% 0 + Disease: Eye , Medicine, Biotechnology


Last highlighted: $VRDN 8-K/A Viridian Therapeutics (15 Jun, 5:30pm) 📰 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (amendment) https://t.co/Ot2kOEW3mb #VRDN #8KA #ViridianTherapeutics #News
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.